Business Description
Evotec SE is a Hamburg-based drug research and development company founded in 1993, operating across the United States, Europe, and other global markets. The company works to discover and develop treatments for a wide range of serious conditions, including cancer, diabetes, heart disease, kidney and liver disorders, and rare diseases, among others. Evotec partners with leading universities, hospitals, research centers, and pharmaceutical companies worldwide to advance its pipeline, and also serves biotech firms, patient groups, and academic institutions.
